CompletedN/Aketamine
Long Term Follow Up KET-PD
Sponsored by Yale University
NCT ID
NCT06164756
Target Enrollment
49 participants
Start Date
2023-10-18
Est. Completion
2026-03-26
About This Study
The purpose of this study is to examine a) the longer-term effects of ketamine for treating depression in Parkinson's disease (PD) and b) the effects of CBT on maintaining the effects of ketamine.
Conditions Studied
Interventions
- •Cognitive Behavior Therapy (CBT)
- •Treatment As Usual (TAU)
Eligibility
Age:40 Years - 80 Years
Healthy Volunteers:No
View full eligibility criteria
Eligibility is determined in the ongoing parent clinical trial (KET-PD trial; NCT04944017, HIC 2000030394).
Study Locations (1)
Yale New Haven Hospital
New Haven, Connecticut, United States